CelLink Corp

SAN CARLOS, CA · CIK 0001759329 · Biotech

3D bioprinters and bioinks for tissue engineering and drug testing

cellink.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$25M
1 Form D · Apr 2021
66 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$24,724,975
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1957Base2 Genomics LLC——
1958PAXVAX, INC.—$58M
1959Synbiotic Health, Inc.—$6.0M
1960CelLink Corp—$25M
1961Vanquish Bio LLC——
1962Humanity Inc.—$2.4M
1963Verastem Oncology——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Malcom BrownDirector · Executive Officer
  • Kevin CoakleyDirector · Executive Officer · Promoter
  • James CrossDirector
  • Bruce GrahamDirector
  • Mark SchulzDirector
  • Jeff YuDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.